It seems that there is not much difference between lucentis at 24 weeks and 52 weeks. really can't figure out how opt-302 could fail within 52 weeks. Maybe Coast will fail, but Shore will win. At least it can be sold to Novartis, which should be worth billions.
Add to My Watchlist
What is My Watchlist?